Another article by many contributors including my good friends Margeruite, Martin and Louise
An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels
http://link.springer.com/article/10.1007%2Fs00415-■■■■■■■■-2